Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olof Akre

Showing results (101-110 of 133) with videos related to

Pageof 14
Sort By:
Clinical Epigenetics|November 1, 2019
DNA methylation in repeat negative prostate biopsies as a marker of missed prostate cancerValentina Fiano, Daniela Zugna, Chiara Grasso, et al.
European Urology|December 2, 2023
Population-based Organised Prostate Cancer Testing: Results from the First Invitation of 50-year-old MenOla Bratt, Rebecka Arnsrud Godtman, Thomas Jiborn, et al.
BMJ Health & Care Informatics|August 3, 2022
Effect of digital-enabled multidisciplinary therapy conferences on efficiency and quality of the decision making in prostate cancer careErik Ronmark, Ralf Hoffmann, Viktor Skokic, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 16, 2004
Testicular cancer incidence in eight northern European countries: secular and recent trendsLorenzo Richiardi, Rino Bellocco, Hans-Olov Adami, et al.
World Journal of Urology|January 6, 2015
Physical activity and body mass index as predictors of prostate cancer riskAlessandra Grotta, Matteo Bottai, Hans-Olov Adami, et al.
European Urology|September 20, 2021
Functional and Oncological Outcomes After Open Versus Robot-assisted Laparoscopic Radical Prostatectomy for Localised Prostate Cancer: 8-Year Follow-upAnna Lantz, David Bock, Olof Akre, et al.
BJU International|October 15, 2013
The impact of length and location of positive margins in predicting biochemical recurrence after robot-assisted radical prostatectomy with a minimum follow-up of 5 yearsPrasanna Sooriakumaran, Achilles Ploumidis, Tommy Nyberg, et al.
The Journal of Urology|July 25, 2024
miR-371a-3p Predicting Viable Tumor in Patients Undergoing Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer: The SWENOTECA-MIR StudyAnna Thor, Mette Pernille Myklebust, Anna Grenabo Bergdahl, et al.
European Urology Focus|July 30, 2017
Oncologic Outcomes After Robot-assisted Radical Prostatectomy: A Large European Single-centre Cohort with Median 10-Year Follow-upPrabhakar Rajan, Anna Hagman, Prasanna Sooriakumaran, et al.
JAMA Network Open|February 2, 2024
Risk of Venous Thromboembolic Events After Surgery for CancerJohan Björklund, Juhana Rautiola, Renata Zelic, et al.
Pageof 14

Showing results (101-110 of 133) with videos related to

Sort By:
Pageof 14
Clinical Epigenetics|November 1, 2019
DNA methylation in repeat negative prostate biopsies as a marker of missed prostate cancerValentina Fiano, Daniela Zugna, Chiara Grasso, et al.
European Urology|December 2, 2023
Population-based Organised Prostate Cancer Testing: Results from the First Invitation of 50-year-old MenOla Bratt, Rebecka Arnsrud Godtman, Thomas Jiborn, et al.
BMJ Health & Care Informatics|August 3, 2022
Effect of digital-enabled multidisciplinary therapy conferences on efficiency and quality of the decision making in prostate cancer careErik Ronmark, Ralf Hoffmann, Viktor Skokic, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 16, 2004
Testicular cancer incidence in eight northern European countries: secular and recent trendsLorenzo Richiardi, Rino Bellocco, Hans-Olov Adami, et al.
World Journal of Urology|January 6, 2015
Physical activity and body mass index as predictors of prostate cancer riskAlessandra Grotta, Matteo Bottai, Hans-Olov Adami, et al.
European Urology|September 20, 2021
Functional and Oncological Outcomes After Open Versus Robot-assisted Laparoscopic Radical Prostatectomy for Localised Prostate Cancer: 8-Year Follow-upAnna Lantz, David Bock, Olof Akre, et al.
BJU International|October 15, 2013
The impact of length and location of positive margins in predicting biochemical recurrence after robot-assisted radical prostatectomy with a minimum follow-up of 5 yearsPrasanna Sooriakumaran, Achilles Ploumidis, Tommy Nyberg, et al.
The Journal of Urology|July 25, 2024
miR-371a-3p Predicting Viable Tumor in Patients Undergoing Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer: The SWENOTECA-MIR StudyAnna Thor, Mette Pernille Myklebust, Anna Grenabo Bergdahl, et al.
European Urology Focus|July 30, 2017
Oncologic Outcomes After Robot-assisted Radical Prostatectomy: A Large European Single-centre Cohort with Median 10-Year Follow-upPrabhakar Rajan, Anna Hagman, Prasanna Sooriakumaran, et al.
JAMA Network Open|February 2, 2024
Risk of Venous Thromboembolic Events After Surgery for CancerJohan Björklund, Juhana Rautiola, Renata Zelic, et al.
Pageof 14